Why does the site say “<155 nm” instead of an exact lower bound?

GC-UV detection extends well into the vacuum-UV, but the exact lower wavelength a given system reaches depends on the flow cell design, window material, carrier-gas purity, optical path length, and the absorbing species in the sample. Quoting a single fixed number would imply a guaranteed limit across all configurations and matrices, which isn't physically accurate. “<155 nm” communicates the meaningful capability — operation in the vacuum-UV — without overstating performance you can't reproduce in your own setup.

What actually limits the lower wavelength?

Three things dominate: (1) absorption by the carrier gas itself (N₂ is largely transparent down to ~145 nm; O₂ and H₂O cut in much earlier), (2) the transmission cutoff of the flow-cell windows (MgF₂, LiF, and synthetic silica each have different deep-UV cutoffs), and (3) lamp emission and detector quantum efficiency at very short wavelengths. INSCAN is engineered so all three are pushed as far into the vacuum-UV as the application requires.

Does GC-UV always operate at the lowest possible wavelength?

No — and it shouldn't. The optimal wavelength window is chosen per analyte. Many compound classes have their strongest, most selective absorption bands above 155 nm. Going lower buys you sensitivity for non-UV-active compounds and class-level fingerprints, but it isn't free: shorter wavelengths require stricter purge, cleaner gas, and shorter optical paths.

How should I interpret the spec sheets?

Treat the published range (typ. <155–330 nm) as the envelope INSCAN can operate within. The wavelength range that's relevant to your method is a subset chosen during method development, based on your analytes, matrix, and required limits of detection. Our applications team confirms the working window during a feasibility scan.

Is “<155 nm” a marketing hedge?

It's the opposite — it's the honest framing. A specific sub-155 nm number would only be defensible under one configuration with one sample. The “<155 nm” phrasing matches how peer-reviewed GC-UV literature describes vacuum-UV operation, and it's consistent with how spectroscopy vendors quote ranges (e.g. “below 200 nm” for deep-UV HPLC detectors).

What does “far below 155 nm” actually mean in practice?

“Far below 155 nm” means the optical path is engineered to keep transmitting useful signal deep into the vacuum-UV — typically into the 130–150 nm region, and in some configurations approaching the LiF cutoff near 105 nm. In that regime almost every organic molecule has a strong σ→σ* or n→σ* absorption, so even compounds that look “UV-transparent” in conventional HPLC detectors (alkanes, fixed gases, simple halocarbons) become detectable with class-specific spectra.

What limits performance at the deepest wavelengths?

Four things, in order of impact: (1) residual O₂ and H₂O in the carrier and purge gas — both absorb strongly below ~180 nm; (2) window contamination — even a monolayer of pump oil, plasticiser, or fingerprint residue raises the cutoff dramatically; (3) lamp ageing — D₂ and Xe lamps lose deep-UV output before they lose visible output; (4) sample loading — overloaded peaks saturate the detector and broaden into the baseline.

How should customers prepare samples for deep-UV GC-UV work?

Treat it like trace GC-MS, with two extra rules. First, eliminate water and oxygen from the sample path: dry solvents, low-bleed septa, and a fresh split liner before any deep-UV run. Second, control matrix loading — dilute heavy matrices so total mass on-column stays below ~100 ng per analyte. Use UV-grade carrier gas (≥99.9999% N₂ or He) with an in-line O₂/H₂O trap.

GC-UV Metabolite & Biomarker Isomer Differentiation

Q: Why does the site say “<155 nm” instead of an exact lower bound?

GC-UV detection extends well into the vacuum-UV, but the exact lower wavelength a given system reaches depends on the flow cell design, window material, carrier-gas purity, optical path length, and the absorbing species in the sample. Quoting a single fixed number would imply a guaranteed limit across all configurations and matrices, which isn't physically accurate. “<155 nm” communicates the meaningful capability — operation in the vacuum-UV — without overstating performance you can't reproduce in your own setup.

Q: What actually limits the lower wavelength?

Three things dominate: (1) absorption by the carrier gas itself (N₂ is largely transparent down to ~145 nm; O₂ and H₂O cut in much earlier), (2) the transmission cutoff of the flow-cell windows (MgF₂, LiF, and synthetic silica each have different deep-UV cutoffs), and (3) lamp emission and detector quantum efficiency at very short wavelengths. INSCAN is engineered so all three are pushed as far into the vacuum-UV as the application requires.

Q: Does GC-UV always operate at the lowest possible wavelength?

No — and it shouldn't. The optimal wavelength window is chosen per analyte. Many compound classes have their strongest, most selective absorption bands above 155 nm. Going lower buys you sensitivity for non-UV-active compounds and class-level fingerprints, but it isn't free: shorter wavelengths require stricter purge, cleaner gas, and shorter optical paths.

Q: How should I interpret the spec sheets?

Treat the published range (typ. <155–330 nm) as the envelope INSCAN can operate within. The wavelength range that's relevant to your method is a subset chosen during method development, based on your analytes, matrix, and required limits of detection. Our applications team confirms the working window during a feasibility scan.

Q: Is “<155 nm” a marketing hedge?

It's the opposite — it's the honest framing. A specific sub-155 nm number would only be defensible under one configuration with one sample. The “<155 nm” phrasing matches how peer-reviewed GC-UV literature describes vacuum-UV operation, and it's consistent with how spectroscopy vendors quote ranges (e.g. “below 200 nm” for deep-UV HPLC detectors).

Q: What does “far below 155 nm” actually mean in practice?

“Far below 155 nm” means the optical path is engineered to keep transmitting useful signal deep into the vacuum-UV — typically into the 130–150 nm region, and in some configurations approaching the LiF cutoff near 105 nm. In that regime almost every organic molecule has a strong σ→σ* or n→σ* absorption, so even compounds that look “UV-transparent” in conventional HPLC detectors (alkanes, fixed gases, simple halocarbons) become detectable with class-specific spectra.

Q: What limits performance at the deepest wavelengths?

Four things, in order of impact: (1) residual O₂ and H₂O in the carrier and purge gas — both absorb strongly below ~180 nm; (2) window contamination — even a monolayer of pump oil, plasticiser, or fingerprint residue raises the cutoff dramatically; (3) lamp ageing — D₂ and Xe lamps lose deep-UV output before they lose visible output; (4) sample loading — overloaded peaks saturate the detector and broaden into the baseline.

Q: How should customers prepare samples for deep-UV GC-UV work?

Treat it like trace GC-MS, with two extra rules. First, eliminate water and oxygen from the sample path: dry solvents, low-bleed septa, and a fresh split liner before any deep-UV run. Second, control matrix loading — dilute heavy matrices so total mass on-column stays below ~100 ng per analyte. Use UV-grade carrier gas (≥99.9999% N₂ or He) with an in-line O₂/H₂O trap.

In metabolomics and biomarker discovery, the hardest problem is rarely detection — it is distinguishing structurally similar isomers that co-elute on GC and produce indistinguishable mass spectra. GC-UV provides a third dimension: a continuous absorbance spectrum that resolves positional and stereo-isomers via their chromophore environment.

The problem

Modern translational labs routinely identify thousands of features per sample. The bottleneck has shifted from detection to identification: positional isomers of monoterpenes, oxidised lipids, and drug-metabolite regio-isomers all share the same molecular formula, the same nominal mass, and frequently the same EI fragmentation pattern.

Researchers either accept ambiguous IDs, run a second LC-MS injection on a different column, or escalate to NMR — none of which scale to discovery throughput.

Method — GC-UV in context with GC-VUV

INSCAN LAB sits between the GC outlet and an existing MS or FID, capturing the spectrum non-destructively. The detector records the full 200–340 nm range every 80 ms, producing a hyperspectral chromatogram that can be deconvoluted into pure component spectra even where peaks overlap.

Where GC-VUV fits

Vacuum-UV (GC-VUV) excels at saturated metabolites with no UV-active chromophore in the > 195 nm window — ketosteroids, simple alkanes, branched lipids — because most molecules absorb somewhere between 125 and 240 nm. For aromatic biomarkers, oxidised lipid metabolites, and most drug regio-isomers, the chromophore is already accessible to UV and INSCAN's spectral resolution is sufficient for unambiguous ID. The operational difference: no vacuum pump, no helium-only requirement, can run on shared bench GC. See our GC-VUV explainer for the wavelength-coverage trade-off.

Spectral deconvolution in practice

For a co-eluting α/β-isomer pair, the algorithm extracts each component's spectrum and independently quantifies them — without manual peak-fitting.

Results

Oxidative biomarker panel: 8-iso-PGF2α resolved from three regio-isomers at baseline on a 60 m mid-polar column in 28 min.
Branched-chain amino acid derivatives: leucine / isoleucine / allo-isoleucine identified by spectrum where EI-MS produced indistinguishable fragmentation.
Pharmacokinetic study of a stereo-isomeric API: enantiomer-pair identification without chiral column re-run.
Researchers report ID confidence comparable to NMR for known references, at injection-rate throughput.

Throughput and lab fit

INSCAN LAB is designed for high-occupancy bench environments — quiet, no vacuum requirement, and a footprint that fits a standard fume hood. Workflows that previously required a dedicated GC-MS shift can now run unattended overnight on a shared GC.